The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Cefepime
Cefepime · CEFEPIME HYDROCHLORIDE 100 g/1 · Injection, Powder, For Solution · Intravenous · Samson Medical Technologies Llc
NDC 66288-8100-01 · 1 BAG in 1 BAG / 1 INJECTION, POWDER, FOR SOLUTION in 1 BAG · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $290.72 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA209408
- TE code
- —
- Approval date
- Aug 21, 2018
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)Feb 10, 2026
- Planned discontinuation — Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)Feb 10, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cefepime (Injection, Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Apotex Corp. | CEFEPIME HYDROCHLORIDE 2 g/1 | Jul 15, 2026 | Sep 3, 2026 |
| WG Critical Care, LLC | CEFEPIME HYDROCHLORIDE 1 g/1 | Jul 15, 2026 | Sep 3, 2026 |
| Fresenius Kabi USA, LLC | CEFEPIME HYDROCHLORIDE 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | CEFEPIME HYDROCHLORIDE 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | CEFEPIME HYDROCHLORIDE 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | CEFEPIME HYDROCHLORIDE 1 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Samson Medical Technologies Llc | CEFEPIME HYDROCHLORIDE 100 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | CEFEPIME HYDROCHLORIDE 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | CEFEPIME HYDROCHLORIDE 1 g/1 | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Cefepime — NDC 66288-8100-01," retrieved September 3, 2026, https://drugdashboards.com/drug/66288810001.
Free to cite with attribution — see how the data is put together.